MEETINGS - Seminar on Minimally Invasive Technologies: Device Design, Testing and Applications (Zurich) November 1999:
This article was originally published in Clinica
Technomic Publishing will hold a seminar on Minimally Invasive Technologies: Device Design, Testing and Applications in Zurich on October 14-15 and in Burlington, Massachusetts, on November 18-19. Delegates will learn about different aspects of minimally invasive techniques including how to: design devices for remote entry and steer the device to the application site within the body; design retrieval procedures; evaluate and test devices; and understand the interaction between human tissues and medical devices and materials. For more information contact Technomic in Switzerland (tel: +41 61 381 5226) or in the US (tel: +1 717 291 5609).
You may also be interested in...
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.